NCT01706809

Brief Summary

The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 11, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 15, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

February 5, 2014

Status Verified

February 1, 2014

Enrollment Period

4 years

First QC Date

October 11, 2012

Last Update Submit

February 4, 2014

Conditions

Rectal Cancer

Outcome Measures

Primary Outcomes (1)

  • The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

    after the study is complete

Study Arms (1)

Biomarkeres

Other: blood sampels from vena rectalis superior and vena cubiti

Interventions

blood sampels from vena rectalis superior and vena cubitiOTHER
Biomarkeres

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing open LAR for rectum cancer is subjected.

You may qualify if:

  • Histological verified cancer
  • The cancer must be located in rectum maximum of 15 cm.
  • Age above 18

You may not qualify if:

  • Disseminated cancer
  • Perioperative radio-chemotherapy
  • Laparoscopy surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vejle hospital

Vejle, Vejle, 5000, Denmark

RECRUITING

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

October 11, 2012

First Posted

October 15, 2012

Study Start

September 1, 2011

Primary Completion

September 1, 2015

Study Completion

December 1, 2015

Last Updated

February 5, 2014

Record last verified: 2014-02

Locations

DK(1)